Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Study of Remdesivir in Participants Below 18 Years Old With COVID-19

ClinicalTrials.gov ID: NCT04431453

Public ClinicalTrials.gov record NCT04431453. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With COVID-19

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goals of this clinical study are to learn more about the study drug, remdesivir, and how safe it is in participants less than 18 years old with coronavirus disease 2019 (COVID-19).

Study identification

NCT ID
NCT04431453
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
59 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 21, 2020 (Actual)
Primary completion
Feb 10, 2023 (Actual)
Completion
Feb 10, 2023 (Actual)
Last update posted
Feb 6, 2024

2020 – 2023

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Children's Hospital of Alabama Birmingham Alabama 35233 —
Children's Hospital Los Angeles Los Angeles California 90027 —
Ronald Reagan University of California, Los Angeles Medical Center Los Angeles California 90095 —
Valley Children's Hospital Madera California 93636 —
UC Davis Medical center Sacramento California 95817 —
Rady Children's Hospital San Diego San Diego California 92123 —
Tampa General Hospital (Inpatient Visits) Tampa Florida 33606 —
Ann & Robert H. Lurie Children's Hospital Chicago Illinois 60611 —
Norton Children's Hospital Louisville Kentucky 40202 —
Tulane University School of Medicine New Orleans Louisiana 70112 —
Johns Hopkins Children's Center Baltimore Maryland 21287 —
Boston Children's Hospital Boston Massachusetts 02115 —
Spectrum Health/Helen De Vos Children's Hospital Grand Rapids Michigan 49503 —
Children's Minnesota Minneapolis Minnesota 55404 —
Northwell Health-Cohen Children's Medical Center New Hyde Park New York 11040 —
NYC Health + Hospitals/Jacobi Medical Center The Bronx New York 10461 —
Montefiore Medical Center The Bronx New York 10467 —
Carolinas Medical Center-Levine Children's Hospital Charlotte North Carolina 28203 —
Lehigh Valley Hospital/Lehigh Valley Health Network (LVH/LVHN) Allentown Pennsylvania 18103 —
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134 —
Children's Medical Center Dallas Texas 75235 —
Texas Children's Hospital Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04431453, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2024 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04431453 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →